C84.7A Faturalandırılabilir, belirli kod Anaplastic large cell lymphoma, ALK-negative, breast
ICD-10-CM C84.7A identifies “Anaplastic large cell lymphoma, ALK-negative, breast” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Bölüm 2: Neoplasms
Kod talimatları
Inclusion terms1
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
Üst düzey talimatlar
Bölümler 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C84 · Mature T/NK-cell lymphomas
Excludes 11
personal history of non-Hodgkin lymphoma (Z85.72)
C84.7 · Anaplastic large cell lymphoma, ALK-negative
Excludes 11
primary cutaneous CD30-positive T-cell proliferations (C86.6-)
Resmî dizin referansları
Resmî dizin referansları (1)
Lymphoma(of) (malignant) (1)
Resmî dönüşüm geçmişi
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Önceki atama: C84.79
Geçmiş
Kod geçmişi
Son kaydedilen değişiklik · FY2022
Yürürlük tarihi
- Eklendi
Anaplastic large cell lymphoma, ALK-negative, breast
Faturalanabilir tanı kodu
CDC/NCHS · FY2022Tüm sürümler (11)
| Tüm sürümler | Yürürlük tarihi | Kod geçmişi |
|---|---|---|
| FY2022 | 2021-10-01 | Eklendi |
| FY2022 · 04-01 | 2022-04-01 | Tabloda değişiklik yok |
| FY2023 | 2022-10-01 | Tabloda değişiklik yok |
| FY2023 · 04-01 | 2023-04-01 | Tabloda değişiklik yok |
| FY2024 | 2023-10-01 | Tabloda değişiklik yok |
| FY2024 · 04-01 | 2024-04-01 | Tabloda değişiklik yok |
| FY2025 | 2024-10-01 | Tabloda değişiklik yok |
| FY2025 · 04-01 | 2025-04-01 | Tabloda değişiklik yok |
| FY2026 | 2025-10-01 | Tabloda değişiklik yok |
| FY2026 · April | 2026-04-01 | Tabloda değişiklik yok |
| FY2027 | 2026-10-01 | Tabloda değişiklik yok |
Bu girdi, seçilen sürümde tam bir koddur. Referans kontrolü klinik uygunluğu belirlemez veya geri ödemeyi garanti etmez.